Wolverine Trading, LLC Amgen Inc Transaction History

Wolverine Trading, LLC

$103 Billion
Q4 2024

A detailed history of Wolverine Trading, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wolverine Trading, LLC holds 47,212 shares of AMGN stock, worth $14.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

47,212

Previous 4,257 1009.04%

Holding current value

$14.5 Million

Previous $1.37 Million 797.52%

% of portfolio

0.01%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$258.78 - $328.31 $11.1 Million - $14.1 Million	42,955 Added 1009.04%	47,212 $12.3 Million
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $1.32 Million - $1.44 Million	4,257 New	4,257 $1.37 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $4.29 Million - $5.18 Million	-15,973 Reduced 10.9%	130,537 $37.1 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $37.5 Million - $42.3 Million	146,510 New	146,510 $42.2 Million
Q2 2023 Aug 23, 2023	BUY	$214.27 - $253.37 $1.09 Million - $1.29 Million	5,105 Added 61.23%	13,442 $2.98 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $39.8 Million - $48.5 Million	-176,116 Reduced 95.48%	8,337 $2.01 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $34 Million - $43.2 Million	148,538 Added 413.58%	184,453 $48.4 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $943,180 - $1.06 Million	-4,202 Reduced 10.47%	35,915 $8.2 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $2.93 Million - $3.26 Million	12,697 Added 46.31%	40,117 $9.85 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $6.01 Million - $6.65 Million	27,420 New	27,420 $6.65 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $5.82 Million - $6.66 Million	-29,272 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $6.21 Million - $7.28 Million	29,272 New	29,272 $6.29 Million
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $4.01 Million - $4.45 Million	-17,153 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $4.9 Million - $5.71 Million	-22,068 Reduced 56.27%	17,153 $4.28 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $2.99 Million - $3.56 Million	13,798 Added 54.27%	39,221 $8.91 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $4.63 Million - $5.14 Million	19,712 Added 345.16%	25,423 $6.31 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $3.29 Million - $4.03 Million	-16,621 Reduced 74.43%	5,711 $1.32 Million
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $4.96 Million - $6.57 Million	-27,191 Reduced 54.91%	22,332 $4.66 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $2.97 Million - $3.82 Million	15,703 Added 46.43%	49,523 $11.9 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $5.7 Million - $6.83 Million	32,736 Added 3019.93%	33,820 $6.59 Million
Q2 2019 Aug 20, 2019	BUY	$166.7 - $195.41 $180,702 - $211,824	1,084 New	1,084 $200,000
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $6.85 Million - $7.72 Million	-37,875 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $3.38 Million - $3.95 Million	18,959 Added 100.23%	37,875 $7.22 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $1.49 Million - $1.67 Million	8,015 Added 73.53%	18,916 $3.92 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $1.85 Million - $2.16 Million	10,901 New	10,901 $1.86 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $3.72 Million - $4.16 Million	-22,046 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $3.69 Million - $4.21 Million	22,046	22,046 $4.11 Million

Others Institutions Holding AMGN

# of Institutions

3,172

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Amgen Inc Transaction History